首页> 外文期刊>Investigative ophthalmology & visual science >Long-Term Survival of Corneal Allografts after Penetrating Keratoplasty and Autologous Cultivated Limbal Epithelial Transplantation
【24h】

Long-Term Survival of Corneal Allografts after Penetrating Keratoplasty and Autologous Cultivated Limbal Epithelial Transplantation

机译:穿透性角膜移植和自体培养的角膜缘上皮移植后角膜同种异体移植物的长期存活

获取原文
           

摘要

? Purpose: ?This study aims to report the long-term survival of corneal allografts in eyes undergoing autologus cultivated limbal epithelial transplantation (CLET) and penetrating keratoplasty (PK). ? Methods: ?This was a retrospective interventional case series that included 43 eyes of 43 patients with unilateral limbal stem cell deficiency (LSCD) due to ocular burns; 10 eyes underwent simultaneous (single-stage) and 33 eyes underwent consecutive (two-stage with minimum interval of 6 weeks) autologous CLET and PK. The medical record of each patient was reviewed for demographics, primary etiology, previous surgical procedures, preoperative and postoperative best corrected visual acuity (BCVA), clinical findings and complications. The primary outcome measure was corneal allograft failure, defined clinically as irreversible loss of central graft clarity. The survival of the corneal allograft was estimated using Kaplan Meier survival analysis. Risk factors of graft failure were analyzed using Cox proportional hazards model. The secondary outcome measures were post-operative best corrected visual acuity (BCVA) and complications. ? Results: ?Most patients were young (median age: 18 years) males (76%) with LSCD due to alkali burns (79%) and a mean follow-up of 4.38 ± 1.84 (range 1 to 8) years. The overall corneal allograft survival was 55.81 ± 7.57% at 1 year (median survival of 2.5 years); the corneal allograft survival after two-stage CLET and PK was 66.67 ± 8.13% at 1 year (median survival of 3.3 years). Single-stage CLET and PK had a greater risk of both corneal allograft failure (hazards ratio 4.5, P=0.006) and recurrence of LSCD (60%, P= 0.02), as compared to two-stage surgery. Failure occurred in 25 eyes due to graft rejection (36%), graft infiltrate (28%), recurrence of LSCD (8%) or combination of causes (28%). One third of the eyes achieved a BCVA of 20/60 or better. The commonest cause for low vision in spite of a clear graft was amblyopia. ? Conclusions: ?The risk of corneal allograft failure in these eyes is high and survival decreases with time; avoiding simultaneous limbal and corneal transplantation and adopting measures to prevent the causes of corneal allograft failure are needed to improve outcomes. ? Keywords: transplantation ? cornea: clinical science?.
机译:?目的:本研究旨在报告接受自体培养角膜缘上皮移植(CLET)和穿透性角膜移植术(PK)的眼睛的同种异体角膜移植的长期存活率。 ?方法:这是一项回顾性介入病例系列研究,包括43例因眼灼伤而导致单侧角膜缘干细胞缺乏症(LSCD)的患者的43只眼;自体CLET和PK同步进行10眼(单阶段),连续33眼(两阶段,最小间隔为6周)。对每位患者的病历进行人口统计学,主要病因,先前的手术程序,术前和术后最佳矫正视力(BCVA),临床发现和并发症进行了回顾。主要结局指标是同种异体角膜移植失败,临床上定义为不可恢复的中央移植透明性丧失。使用Kaplan Meier生存分析评估同种异体角膜的生存。使用Cox比例风险模型分析了移植失败的危险因素。次要结果指标是术后最佳矫正视力(BCVA)和并发症。 ?结果:?大多数患者为年轻人(中位年龄:18岁),因碱烧伤(79%)而接受LSCD的LSCD(79%),平均随访时间为4.38±1.84(1至8)年。同种异体角膜移植物在1年时的总生存率为55.81±7.57%(中位生存期为2.5年);两阶段CLET和PK后1年的角膜同种异体移植存活率为66.67±8.13%(中位存活期为3.3年)。与两阶段手术相比,单阶段CLET和PK的角膜同种异体移植失败风险比(风险比4.5,P = 0.006)和LSCD复发的风险更高(60%,P = 0.02)。 25眼因移植物排斥反应(36%),移植物浸润(28%),LSCD复发(8%)或多种原因(28%)而发生衰竭。三分之一的眼睛的BCVA达到20/60或更高。尽管移植物清晰可见,但导致低视力的最常见原因是弱视。 ?结论:?这些眼睛的角膜同种异体移植失败的风险很高,存活率随时间而降低。避免同时进行角膜缘和角膜移植,并采取措施防止角膜同种异体移植失败的原因,以改善治疗效果。 ?关键字:移植?角膜:临床科学?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号